Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,335 CAD | 0,00% | -5,63% | -14,10% |
27/03 | Transcript : Microbix Biosystems Inc. - Shareholder/Analyst Call | |
14/03 | Microbix' medicijnproject tegen klontervorming vordert | CI |
Omzet 2024 * | 18,59 mln. 25,37 mln. 17,32 mln. | Omzet 2025 * | 21,32 mln. 29,1 mln. 19,86 mln. | Marktkapitalisatie | 33,6 mln. 45,87 mln. 31,31 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | - | Nettowinst (verlies) 2025 * | - | EV/omzet 2024 * | 1,81 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 1,58 x |
K/w-verhouding 2024 * |
16,8
x | K/w-verhouding 2025 * |
16,8
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 85,65% |
Recentste transcriptie over Microbix Biosystems Inc.
1 week | -5,63% | ||
Lopende maand | -8,22% | ||
1 maand | -10,67% | ||
3 maanden | -14,10% | ||
6 maanden | +15,52% | ||
Lopend jaar | -14,10% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Cameron Groome
CEO | Chief Executive Officer | - | 08-03-12 |
James Currie
DFI | Director of Finance/CFO | - | 01-11-16 |
Mark Luscher
CTO | Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Mark Cochran
BRD | Director/Board Member | - | 01-10-90 |
Peter Blecher
BRD | Director/Board Member | - | 06-12-05 |
Cameron Groome
CEO | Chief Executive Officer | - | 08-03-12 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
25-04-24 | 0,335 | 0,00% | 2 500 |
24-04-24 | 0,335 | 0,00% | 21 500 |
23-04-24 | 0,335 | -1,47% | 44 286 |
22-04-24 | 0,34 | 0,00% | 41 786 |
19-04-24 | 0,34 | -4,23% | 68 486 |
uitgestelde koers Toronto S.E., 25 april 2024 om 18:42 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-14,10% | 33,6 mln. | |
+1,12% | 42,59 mld. | |
+6,77% | 40,65 mld. | |
+47,58% | 40,57 mld. | |
-11,96% | 26,77 mld. | |
+6,01% | 24,81 mld. | |
-24,92% | 18,17 mld. | |
-3,63% | 11,7 mld. | |
+27,16% | 12,05 mld. | |
+7,30% | 11,1 mld. |